Länder Analysen: Großbritannien
| 14.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.05.24 | RELX Buy | UBS AG | |
| 14.05.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 14.05.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 14.05.24 | Vodafone Group Buy | UBS AG | |
| 13.05.24 | Diageo Sell | UBS AG | |
| 13.05.24 | National Grid Buy | UBS AG | |
| 13.05.24 | GSK Buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 13.05.24 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.05.24 | National Grid Overweight | Barclays Capital | |
| 13.05.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 13.05.24 | GSK Buy | Jefferies & Company Inc. | |
| 10.05.24 | Reckitt Benckiser Buy | UBS AG | |
| 10.05.24 | Vodafone Group Buy | UBS AG | |
| 09.05.24 | National Grid Buy | UBS AG | |
| 09.05.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.05.24 | BP Buy | Jefferies & Company Inc. | |
| 08.05.24 | HSBC Sector Perform | RBC Capital Markets | |
| 08.05.24 | GSK Outperform | Bernstein Research | |
| 08.05.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.05.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 08.05.24 | BP Buy | UBS AG | |
| 07.05.24 | Reckitt Benckiser Buy | UBS AG | |
| 07.05.24 | BP Buy | UBS AG | |
| 07.05.24 | BP Buy | Goldman Sachs Group Inc. | |
| 07.05.24 | BP Buy | Jefferies & Company Inc. | |
| 07.05.24 | BP Outperform | RBC Capital Markets | |
| 07.05.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.05.24 | GSK Buy | UBS AG | |
| 06.05.24 | Linde Buy | Jefferies & Company Inc. | |
| 03.05.24 | HSBC Equal Weight | Barclays Capital | |
| 03.05.24 | Diageo Overweight | Barclays Capital | |
| 03.05.24 | National Grid Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.05.24 | Diageo Hold | Jefferies & Company Inc. | |
| 03.05.24 | Linde Kaufen | DZ BANK | |
| 03.05.24 | easyJet Buy | Deutsche Bank AG | |
| 03.05.24 | Diageo Underperform | RBC Capital Markets | |
| 03.05.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 03.05.24 | GSK Halten | DZ BANK | |
| 03.05.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 03.05.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Kaufen | DZ BANK | |
| 02.05.24 | HSBC Buy | Goldman Sachs Group Inc. | |
| 02.05.24 | GSK Buy | Deutsche Bank AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.05.24 | HSBC Neutral | UBS AG | |
| 02.05.24 | GSK Buy | UBS AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |